CardioGenics Holdings Inc. (OTCMKTS:CGNH – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares trading hands.
CardioGenics Stock Performance
CardioGenics Company Profile
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Read More
- Five stocks we like better than CardioGenics
- Upcoming IPO Stock Lockup Period, Explained
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- Investing In Automotive Stocks
- Is IBM’s AI Transformation Powering a Sustained Rally?
- What is a Bond Market Holiday? How to Invest and Trade
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
